Clinical Trial Update: POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating hemostatic potential and joint health in severe Hemophilia A patients on novel replacement therapies has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hemophilia A, Factor VIII | Phase 4 | Status: WITHDRAWN